Although more than two fifths of lung cancers are diagnosed in patients over 70, data from clinical trials on the safest and most effective treatments for this age group are scarce. Now oncologists are conducting a number of trials targeting elderly patients with non-small cell lung cancer, and offer a review of the latest findings - and their recommendations.